BioWorld

Dec. 2, 2010

NewCo News: Acylin Pharma Explores 'Blooming' Acetylation Field

Germany's SuppreMol Raises $20.3M, Secures Path to 2013

Clinic Roundup

Stock Movers

Other News To Note

Axcan Agrees to Acquire Eurand in $583M Deal

Axcan Holdings Inc. will acquire Eurand NV for $12 per share in cash, a $583 million transaction that the companies expect to close in the second quarter of 2011. (BioWorld Today) Read More

Bayh-Dole Brought Shelved Inventions to Marketplace

Today's news in brief

BioWorld

BioWorld briefs for June 4, 2026.

ASCO 2026: A revolution in pancreatic cancer

BioWorld

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 2, 2026

EASL 2026: Emerging liver disease targets to watch

BioWorld

At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...

Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

BioWorld

Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...